In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: Therapeutic effect on liver fibrosis/cirrhosis

Table 2 Inflammation scores in each group (n = 10, mean ± SD)

	Liver fibrosis groups			Liver cirrhosis groups
	1 wk	2 wk	4 wk	2 wk	4 wk	8 wk
Saline/CCl4	1.63 ± 0.05	1.95 ± 0.06	2.67 ± 0.08	3.09 ± 0.07	3.61 ± 0.09	4.12 ± 0.11
MSCs/CCl4	1.25 ± 0.04	1.45 ± 0.05a	1.75 ± 0.07b	2.15 ± 0.06c	2.28 ± 0.07d	3.06 ± 0.08d

^aP < 0.05 vs Saline/CCl₄ 2 wk,

^bP < 0.05 vs Saline/CCl₄ 4 wk (in the liver fibrosis groups);

^cP < 0.05 vs Saline/CCl₄ 2 wk,

^dP < 0.01 vs Saline/CCl₄ 4 wk, (in the liver cirrhosis groups).